Business

Buffalo Grove company buys Clarus Therapeutics drug

Posted October 18, 2022 11:00 pm

NORTHBROOK - Clarus Therapeutics Inc. selected Tolmar Inc. in Buffalo Grove as the winning bidder in a competitive auction for the sale of Jatenzo, a testosterone steroid capsule drug.

The bidding and auction procedures were approved by the U. S. Bankruptcy Court for the District of Delaware and the sale of Jatenzo and certain related assets remain subject to final bankruptcy court approval on Oct. 26, the company said.

Northbrook-based Clarus is a pharmaceutical company with expertise in developing androgen-based medicines. It's first commercial product was Jatenzo. Clarus filed the voluntary Chapter 11 bankruptcy petition last month.

Tolmar is a specialty pharmaceutical company whose portfolio includes products for urology, oncology and dermatology.

Article Comments

Article Categories
Business Health Care

Article Comments

Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked. If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.